Increased myocardial collagen turnover in patients with progressive cardiac conduction disease

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 10, 2008, Pages 1284-1290

  Bozkaya, Yasemin T ^a   Aydin, Hikmet H ^a   Celik, Handan A ^a   Kayikcioglu, Meral ^a   Payzin, Serdar ^a   Kultursay, Hakan ^a   Aydin, Mehmet ^b   Yesil, Murat ^c   Can, Levent H ^a   Hasdemir, Can ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Izmir Tepecik Training and Research Hospital   (Turkey)

^c Ataturk Teaching Hospital   (Turkey)

Author keywords

Collagen; Electrophysiology; Fibrosis; Heart block; Matrix metalloproteinases; Myocardium

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CARBOXY TERMINAL TELOPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LAMININ; OSTEOGENIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MALE; PROGRESSIVE CARDIAC CONDUCTION DEFECT; PROTEIN BLOOD LEVEL; SINUS RHYTHM;

AGED; COLLAGEN; ENDOMYOCARDIAL FIBROSIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; PRE-EXCITATION SYNDROMES;

EID: 51849130481     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01179.x     Document Type: Article

References (31)

1. Davies MJ. Pathology of chronic A-V Block. Acta Cardiol 1976 21 : 19 30.
2. Lev M, Bharati S. Lesions of the conduction system and their functional significance. Pathol Annu 1974 9 : 157 207.
3. Ohkawa S, Hackel DB, Ideker RE. Correlation of the width of the QRS complex with the pathologic anatomy of the cardiac conduction system in patients with chronic complete atrioventricular block. Circulation 1981 63 : 938 947.
4. Ohkawa S, Sugiura M, Itoh Y, Kitano K, Hiraoka K, Ueda K, Murakami M. Electrophysiologic and histologic correlations in chronic complete atrioventricular block. Circulation 1981 64 : 215 231.
5. Waller BF. Clinicopathological correlations of the human cardiac conduction system. In : Zipes DP, Jalife J (eds.) : Cardiac Electrophysiology. From Cell to Bedside. Philadelphia, WB Saunders Co., 1990, pp. 249 269.
6. Uemura A, Morimoto S, Hiramitsu S, Hishida H. Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: Presence of myocarditis. Jpn Heart J 2001 42 : 691 700.
7. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, Wilde AA, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999 23 : 20 21.
8. Lev M. Anatomic basis for atrioventricular block. Am J Med 1964 37 : 742 748.
9. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis 1964 6 : 409 444.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978 58 : 1072 1083.
11. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986 57 : 450 458.
12. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991 114 : 345 352.
13. Chou TC. Electrocardiography in Clinical Practice. Adult and Pediatric. Philadelphia, W Saunders Co., 1996, pp. 448 470.
14. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, et al. Diastolic heart failure: Evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007 115 : 888 895.
15. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006 113 : 2089 2096.
16. Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M, D'Alessandro G, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 2003 108 : 1455 1460.
17. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev 2004 25 : 543 567.
18. Probst V, Kyndt F, Potet F, Trochu JN, Mialet G, Demolombe S, Schott JJ, et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. J Am Coll Cardiol 2003 41 : 643 652.
19. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000 15 : 264 272.
20. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007 117 : 568 575.
21. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 2007 87 : 1285 1342.
22. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007 74 : 207 212.
23. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007 13 : 952 961.
24. Towbin JA. Scarring in the heart - a reversible phenomenon? N Engl J Med 2007 357 : 1767 1768.
25. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001 38 : 1222 1226.
26. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002 105 : 2512 2517.
27. Lopez B, Gonzalez A, Querejeta R, Diez J. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease. J Hypertens 2005 23 : 1445 1451.
28. Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Martinez Ubago JL, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000 101 : 1729 1735.
29. Alla F, Kearney-Schwartz A, Radauceanu A, Das Dores S, Dousset B, Zannad F. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur J Heart Fail 2006 8 : 147 153.
30. Lindsay MM, Maxwell P, Dunn FG. TIMP-1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002 40 : 136 141.
31. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005 45 : 657 687.